On this page
West syndrome (genetic)
West syndrome is a rare and severe epileptic encephalopathy primarily affecting infants, leading to distinctive seizures called infantile spasms and significant developmental challenges. While some cases have identifiable causes, genetic factors play a significant role in many individuals.
Available at Jeen Health
Clinical tests that include this
Overview
West syndrome, also known as infantile spasms, is a rare and severe epileptic encephalopathy that typically manifests within the first year of life, often between 3 and 7 months of age [PMID:33604085]. It is characterised by a specific trio of features: infantile spasms, a unique abnormal brainwave pattern called hypsarrhythmia visible on an electroencephalogram (EEG), and developmental delay or regression [PMID:31194451]. The spasms can be subtle, sometimes mistaken for colic or startle reflexes, but they represent a serious form of epilepsy that can have a profound impact on a child's development.
The syndrome can arise from various underlying causes, including brain malformations, infections, or metabolic disorders. However, a significant proportion of cases, particularly those without an obvious structural or metabolic cause, are linked to genetic factors. The exact prevalence of West syndrome is estimated to be approximately 3 in 10,000 live births, making it one of the more common forms of epilepsy in infancy [PMID:33604085]. Early recognition and treatment are crucial to try and improve developmental outcomes.
Symptoms & clinical features
The hallmark symptom of West syndrome is the presence of infantile spasms. These are sudden, brief contractions of the body, often involving a characteristic 'jackknife' or 'salaam' movement where the infant's head and trunk flex forward, and their arms and legs stiffen [PMID:31194451]. Some spasms may be more subtle, appearing as a slight head nod, eye deviation, or stiffening of the limbs. They typically occur in clusters, often upon waking or falling asleep, and can happen multiple times a day.
In addition to the spasms, infants with West syndrome usually show developmental regression. This means they may lose skills they had previously acquired, such as sitting up, babbling, or social interaction [PMID:31194451]. New learning may also be significantly impaired. The third key feature is a distinctive chaotic brainwave pattern called hypsarrhythmia, which is identified through an EEG. This pattern reflects widespread brain dysfunction. Other symptoms can include irritability, feeding difficulties, and a general slowing of development before the onset of spasms.
Video: Genetics 101
Affected organs
West syndrome primarily affects the brain. The underlying causes lead to widespread disruption of normal brain function, particularly impacting neural networks involved in motor control, cognitive development, and seizure regulation. The characteristic hypsarrhythmia seen on EEG reflects global cerebral dysfunction rather than a localised area of damage. While the symptoms are neurological, the syndrome itself is often a manifestation of an underlying condition that can affect various body systems. For example, some genetic causes, such as those related to Tuberous Sclerosis Complex, can involve the skin, kidneys, heart, and lungs, in addition to the brain.
Risks & severity
West syndrome is a severe epileptic encephalopathy, meaning the epilepsy itself contributes to developmental impairment. The prognosis for children with West syndrome can vary widely depending on the underlying cause and the speed of treatment. Untreated or poorly controlled infantile spasms can lead to significant and permanent developmental delays, intellectual disability, and a higher risk of developing other types of epilepsy, including Lennox-Gastaut syndrome, later in childhood [PMID:33604085].
The age of onset is typically between 3 and 7 months, but it can occur from birth up to around 2 years of age. Severity is influenced by whether an underlying cause is identified ('symptomatic' cases) or if no clear cause is found ('cryptogenic' or 'idiopathic' cases). Children with symptomatic West syndrome, particularly those with brain malformations or other significant neurological damage, generally have poorer developmental outcomes. Even with treatment, many children will experience ongoing developmental challenges. There is no specific lifetime risk percentage, as the condition primarily affects early childhood.
Genetic causes
While West syndrome can arise from various non-genetic causes, a significant number of cases are associated with changes in specific genes. These genes play crucial roles in brain development and function. For instance, pathogenic variants in the ARX gene (aristaless related homeobox) are known to cause X-linked intellectual disability syndromes, which can include West syndrome. The ARX gene product is a transcription factor, essential for regulating other genes involved in early brain development, particularly neuronal migration and differentiation.
Another gene implicated in West syndrome is CDKL5 (cyclin dependent kinase like 5). The protein encoded by CDKL5 is highly active in the brain and is vital for neuronal formation, growth, and signalling. Pathogenic changes in CDKL5 often lead to CDKL5 deficiency disorder, characterised by early-onset seizures (including infantile spasms) and severe developmental delays. Furthermore, variants in TSC1 (TSC complex subunit 1) and TSC2 (TSC complex subunit 2) are associated with Tuberous Sclerosis Complex (TSC). TSC is a multisystem disorder that can cause benign tumours (hamartomas) in various organs, including the brain, which can lead to epilepsy such as West syndrome. The TSC1 and TSC2 genes produce proteins that work together as a tumour suppressor complex, crucial for controlling cell growth and division; disruption of this complex can lead to tumour formation and neurological symptoms.
- ARX aristaless related homeoboxThe ARX gene provides instructions for a protein essential in brain development, influencing the migration and communication of nerve cells and the formation of the pancreas, testes, and skeletal muscles.
- CDKL5 cyclin dependent kinase like 5The CDKL5 gene provides instructions for a protein crucial for normal brain development and function, with variants in this gene linked to severe neurological conditions.
- TSC1 TSC complex subunit 1The TSC1 gene provides instructions for producing hamartin, a protein that plays a vital role in regulating cell growth, proliferation, and size.
- TSC2 TSC complex subunit 2TSC2 encodes tuberin, a tumour suppressor protein that regulates cell growth and division, with pathogenic variants causing tuberous sclerosis complex and related disorders.
Inheritance pattern
The inheritance pattern for West syndrome is varied and depends entirely on the specific underlying genetic cause. For cases linked to the ARX gene, the inheritance is X-linked recessive. This means the gene is located on the X chromosome. Males, who have one X and one Y chromosome, are more commonly and severely affected than females, who have two X chromosomes. Females carrying one pathogenic variant on an X chromosome are typically unaffected carriers but can pass the variant to their children.
For genes like CDKL5, pathogenic variants often arise de novo, meaning they are a new change in the affected individual and are not inherited from either parent. However, if a parent has a mosaic pathogenic variant (present in some cells but not all), there can be a small chance of recurrence. For Tuberous Sclerosis Complex (caused by TSC1 or TSC2 variants), the inheritance is autosomal dominant. This means only one copy of the altered gene is needed to cause the condition. An affected individual has a 50% chance of passing the pathogenic variant to each child, regardless of the child's sex. However, a significant number of TSC cases also arise from new, de novo variants. Genetic counselling is essential to understand the specific inheritance risks for a family.
Diagnosis & testing
Diagnosis of West syndrome typically involves a combination of clinical assessment and specific investigations. The key diagnostic criteria are the presence of infantile spasms, evidence of developmental regression or arrest, and the characteristic hypsarrhythmia pattern on an electroencephalogram (EEG). An EEG is a non-invasive test that measures electrical activity in the brain and is crucial for confirming the diagnosis.
Once West syndrome is suspected, further investigations are undertaken to identify the underlying cause. This often includes a brain MRI scan to check for structural abnormalities, and metabolic screening tests. For cases where no structural or metabolic cause is found, or if there are other clinical features suggestive of a genetic condition, genetic testing is often recommended. In the UK, genetic testing for epilepsy syndromes, including those associated with West syndrome, is typically accessed via the NHS Genomic Medicine Service (GMS) through R-codes such as R47 (developmental and epileptic encephalopathy) or R143 (Tuberous Sclerosis Complex) as indicated by a specialist. Referral to a paediatric neurologist or a clinical geneticist is the usual pathway for initiating these investigations and accessing genetic counselling.
Management & lifestyle
The management of West syndrome focuses on controlling the seizures and supporting the child's development. Treatment for infantile spasms typically involves specific medications, such as vigabatrin or corticosteroids (e.g., prednisolone or adrenocorticotropic hormone, ACTH), which can be effective in stopping the spasms in some children [PMID:31194451]. The choice of treatment often depends on the identified underlying cause, if any, and the individual's response.
In addition to seizure control, a comprehensive management plan includes developmental therapies to support the child's progress. This often involves physiotherapy, occupational therapy, and speech and language therapy. For children with an identified genetic cause, management may also involve addressing other symptoms associated with the underlying condition. For example, individuals with Tuberous Sclerosis Complex will require multi-system surveillance for other manifestations of their condition. All care is typically coordinated through a paediatric neurologist within the NHS, with input from clinical geneticists and genetic counsellors to provide ongoing support and information to families. Lifestyle considerations might include ensuring a safe environment due to seizure risk and optimising nutrition, though these are secondary to medical and therapeutic interventions.
UK care pathway
In the UK, individuals suspected of having West syndrome are typically referred to a paediatric neurologist. Following initial clinical assessment and diagnostic tests, such as EEG and brain MRI, further investigations into genetic causes may be initiated. This pathway usually involves referral to a clinical genetics service or a specialist paediatric epilepsy clinic within the NHS Genomic Medicine Service (GMS).
Genetic testing is accessed through specific R-codes, such as R47 for developmental and epileptic encephalopathies, or R143 if Tuberous Sclerosis Complex is suspected. These tests are usually requested by a clinical geneticist or a paediatric neurologist. Genetic counsellors play a crucial role in providing families with information about inheritance patterns, recurrence risks, and implications for other family members, as well as offering psychological support throughout the diagnostic journey and beyond.
Frequently asked questions
What causes West syndrome?
West syndrome can have many causes, including brain malformations, infections, or metabolic problems. In many cases, it is caused by changes in specific genes, such as ARX, CDKL5, TSC1, or TSC2. Sometimes, no clear cause is identified.
How is West syndrome diagnosed?
Diagnosis involves observing the characteristic infantile spasms, assessing developmental delays, and confirming a specific abnormal brainwave pattern called hypsarrhythmia with an EEG (electroencephalogram). Further tests like MRI scans and genetic testing help identify the underlying cause.
Can West syndrome be treated?
Yes, treatments aim to stop the seizures and support development. Medications like vigabatrin or corticosteroids are often used. Developmental therapies such as physiotherapy, occupational therapy, and speech and language therapy are also crucial for supporting the child's progress.
What are the long-term effects of West syndrome?
The long-term effects vary greatly depending on the underlying cause and how quickly treatment starts. Many children experience ongoing developmental delays, intellectual disability, and may develop other types of epilepsy later in life, such as Lennox-Gastaut syndrome.
How does West syndrome affect families?
Living with West syndrome can be very challenging for families. It often requires significant medical care, therapies, and adjustments to daily life. Genetic counselling can help families understand the condition, its inheritance, and provide support. Support groups can also offer valuable resources and connection.